(1) Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; (2) Coronary Intensive Care Unit, Department of Internal Medicine and Cardiology, Federico II University, Naples, Italy

(1) Division of Oncology/Hematology/BMT, Child & Family Research Institute, BC Children’s Hospital, Vancouver, British Columbia, Canada; (2) Department of Paediatric Hematology, Oncology and Hemostaseology, Children’s Hospital, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; (3) Medilys Laboratory, Hamburg, Germany; (4) Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

(1) Haemostasis Research Unit, Centre for Haemophilia and Thrombosis, Guy’s and St Thomas’s NHS Foundation Trust & King’s College London School of Medicine, London, UK; (2) Center for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark

(1) Hematology Laboratory, UCL Mont-Godinne, Yvoir, Belgium; (2) Department of Pharmacy, Drug Design and Discovery Center, FUNDP, University of Namur, Namur, Belgium; (3) Blood Transfusion Center, UCL Mont-Godinne, Yvoir, Belgium; (4) Hematology Department, UCL Mont-Godinne, Yvoir, Belgium